2023
DOI: 10.3389/fimmu.2022.1063002
|View full text |Cite
|
Sign up to set email alerts
|

Generation of bispecific antibodies by structure-guided redesign of IgG constant regions

Abstract: Bispecific antibodies (BsAbs) form an exciting class of bio-therapeutics owing to their multispecificity. Although numerous formats have been developed, generation of hetero-tetrameric IgG1-like BsAbs having acceptable safety and pharmacokinetics profiles from a single cell culture system remains challenging due to the heterogeneous pairing between the four chains. Herein, we employed a structure-guided approach to engineer mutations in the constant domain interfaces (CH1-CL and CH3-CH3) of heavy and κ light c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 61 publications
0
1
0
Order By: Relevance
“…The use of biological approaches to generate bispecic antibodies was started two decades ago [20][21][22] such as the knobs-intoholes strategy, 23 strand-exchange engineered domain (SEED) CH 3 heterodimers approach, 24 orthogonal Fab interface, 25 and CorssMab design. 26 Recently, chemical approaches [27][28][29][30][31][32][33][34][35] to develop bispecic antibodies has recently emerged, which shows advantages in the bispecic antibody production.…”
Section: Introductionmentioning
confidence: 99%
“…The use of biological approaches to generate bispecic antibodies was started two decades ago [20][21][22] such as the knobs-intoholes strategy, 23 strand-exchange engineered domain (SEED) CH 3 heterodimers approach, 24 orthogonal Fab interface, 25 and CorssMab design. 26 Recently, chemical approaches [27][28][29][30][31][32][33][34][35] to develop bispecic antibodies has recently emerged, which shows advantages in the bispecic antibody production.…”
Section: Introductionmentioning
confidence: 99%